AGC
JAZZ icon

Angelo Gordon & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Angelo Gordon & Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,822
Closed -$1.39M – 235
2021
Q2 		$1.39M Buy
+7,822
New +$1.35M 0.07% 95

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Angelo Gordon & Co's JAZZ Position: Q3 2021 in Review

Angelo Gordon & Co sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 7,822 shares — an estimated $1.39M sold.

Angelo Gordon & Co first reported a position in JAZZ in Q2 2021 and held it in 1 quarter. The position peaked at $1.39M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Angelo Gordon & Co reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Angelo Gordon & Co sold 7,822 Jazz Pharmaceuticals shares in Q3 2021, an estimated $1.39M.
  • Angelo Gordon & Co first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Angelo Gordon & Co's Jazz Pharmaceuticals position peaked at $1.39M in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Angelo Gordon & Co's 13F filing for Q3 2021, filed 15 Nov 2021.